FDA Approval of Epcoritamab for Relapsed or Refractory Follicular Lymphoma

Epcoritamab

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

Insights from the European Cancer Summit 2025: Accelerating HPV-Related Cancer Elimination in Europe

European Cancer Summit 2025

Triplet Therapy Shows Promising Outcomes in MSS BRAF V600E Metastatic Colorectal Cancer More I

Target Therapy

Cecilia Pompili: New Analysis of Resectable NSCLC Trials With ICIs and TKIs

Cecilia Pompili

Eugene Woods Announced the Launch of the Advocate Health National Center for Clinical Trials

Eugene Woods

Raymond Chan: Major Opportunities to Support The More Than 13 Million Cancer Survivors Across Western Pacific

Raymond Chan: Major Opportunities to Support The More Than 13 Million Cancer Survivors Across Western Pacific

NCI Cancer Moonshot Biobank